AI assistant
Axogen, Inc. — Director's Dealing 2022
Feb 17, 2022
32414_dirs_2022-02-17_2d57f047-4ca3-44ee-84d5-86c043d52f23.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-02-15
Reporting Person: Friedman Mark Louis (VP Regulatory Affairs & Policy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-15 | Common Stock | A | 1181 | — | Acquired | 20202 | Direct |
| 2022-02-15 | Common Stock | F | 357 | $8.42 | Disposed | 19845 | Direct |
Footnotes
F1: This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.
F2: Includes 1,569 shares acquired under the Axogen stock purchase plan on December 31, 2021.
F3: The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022.